Impaired neurotransmitter systems by Aβ amyloidosis in APPsw transgenic mice overexpressing amyloid β protein precursor

Neuroscience Letters

Volumn 292, Issue 3, 2000, Pages 155-158

  Tomidokoro, Yasushi ^a   Harigaya, Yasuo ^a   Matsubara, Etsuro ^a   Ikeda, Masaki ^a   Kawarabayashi, Takeshi ^a   Okamoto, Koichi ^a   Shoji, Mikio ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

A ; Alzheimer's disease; Choline acetyltransferase; Somatostatin; Substance P; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLINE ACETYLTRANSFERASE; NEUROTRANSMITTER; SOMATOSTATIN; SUBSTANCE P;

ALZHEIMER DISEASE; AMNESIA; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

AMYGDALA; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMAL; BRAIN STEM; CEREBELLUM; CEREBRAL CORTEX; CHOLINE O-ACETYLTRANSFERASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEURITES; NEURONS; NEUROTRANSMITTERS; OLFACTORY BULB; SENILE PLAQUES; SOMATOSTATIN; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T;

EID: 0034644951     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01443-9     Document Type: Article

References (16)

1. Armstrong D.M., Terry R.D. Substance P immunoreactivity within neuritic plaques. Neurosci. Lett. 58:1985;139-144.
2. Armstrong D.M., Bruce G., Hersh L.B., Terry R.D. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain. Neurosci. Lett. 71:1986;229-234.
3. Beach T.G., Kuo Y.-M., Spiegel K., Emmerling M.R., Sue L.I., Kokjohn K., Roher A.E. The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer Disease. J. Neuropathol. Exp. Neurol. 59:2000;308-313.
4. Benzing W.C., Brady D.R., Mufson E.J., Armstrong D.M. Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of non-demented elderly and Alzheimer's disease patients. Brain Res. 619:1993;55-68.
5. Crystal H.A., Davies P. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. J. Neurochem. 38:1982;1781-1784.
6. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature. 288:1980;279-280.
7. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403.
8. Harigaya Y., Shoji M., Kawarabayashi T., Kanai M., Nakamura T., Iizuka T., Igeta Y., Saido T.C., Sahara N., Mori H., Hirai S. Modified amyloid β protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease. Biochem. Biophys. Res. Commun. 211:1995;1015-1022.
9. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
10. Sw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
11. Kawarabayashi T., Shoji M., Sato M., Sasaki A., Ho L., Eckman C.B., Prada C.M., Younkin S.G., Kobayashi T., Tada N., Matsubara E., Iizuka T., Harigaya Y., Kasai K., Hirai S. Accumulation of β-amyloid fibrils in pancreas of transgenic mice. Neurobiol. Aging. 17:1996;215-222.
12. Morrison J.H., Rogers J., Scherr S., Benoit R., Bloom F.E. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature. 314:1985;90-92.
13. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and βAPP mutations linked to familial Alzheimer's disease. Nature Med. 2:1996;864-870.
14. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
15. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
16. Wong T.P., Debeir T., Duff K., Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19:1999;2706-2716.